oleanolic acid has been researched along with Degenerative Diseases, Central Nervous System in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Huang, X; Li, B; Li, L; Li, Y; Liu, J; Song, D | 1 |
| Ai, Q; Chen, C; Shi, A; Wang, L; Wang, N; Wei, Y | 1 |
| Arandarcikaite, O; Bendokas, V; Gudoityte, E; Liobikas, J; Mazeikiene, I | 1 |
| Chen, Y; Xu, Y; Yang, H; Yu, L | 1 |
| Chang, CH; Liao, VH; Wei, CC | 1 |
| Kim, BM | 1 |
| Beutler, JA; Cho, N; Hong, J; Kim, HW; Moon, EH; Sung, SH | 1 |
| Cichewicz, RH; Du, L; Dunn, DE; He, DN; Kaltenbach, LS; Lo, DC; McCoy, DD; Newman, RA; Peng, J; Shah, B; Shen, L; Van Kanegan, MJ; Yang, P | 1 |
| Law, BY; Liu, L; Lo, AC; Wong, VK; Wu, AG; Zeng, W; Zhu, YZ | 1 |
| Kordower, JH; Masliah, E; McKay, H; Merrill, DA; Mufson, EJ; Roberts, JA; Tuszynski, MH | 1 |
| Beal, MF; Calingasan, NY; Chaturvedi, RK; Kiaei, M; Liby, KT; Morrow, JD; Musiek, ES; Risingsong, R; Royce, D; Sporn, M; Thomas, B; Wille, EJ; Williams, C; Yang, L | 1 |
| Beal, MF; Calingasan, NY; Damiano, M; Kiaei, M; Liby, KT; Naseri, N; Neymotin, A; Petri, S; Risingsong, R; Sporn, M; Wille, E | 1 |
3 review(s) available for oleanolic acid and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Oleanolic acid and ursolic acid: therapeutic potential in neurodegenerative diseases, neuropsychiatric diseases and other brain disorders.
Topics: Brain Diseases; Humans; Neurodegenerative Diseases; Oleanolic Acid; Quality of Life; Triterpenes; Ursolic Acid | 2023 |
Ursolic and Oleanolic Acids: Plant Metabolites with Neuroprotective Potential.
Topics: Animals; Drug Development; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Oleanolic Acid; Plant Extracts; Triterpenes; Ursolic Acid | 2021 |
The Role of Saikosaponins in Therapeutic Strategies for Age-Related Diseases.
Topics: Apoptosis; Cardiovascular Diseases; Cell Cycle Checkpoints; Humans; Liver Diseases; Neoplasms; Neurodegenerative Diseases; Obesity; Oleanolic Acid; Oxidative Stress; Saponins | 2018 |
9 other study(ies) available for oleanolic acid and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Saikosaponin-D Mitigates Oxidation in SH-SY5Y Cells Stimulated by Glutamate Through Activation of Nrf2 Pathway: Involvement of PI3K.
Topics: Apoptosis; Cell Line, Tumor; Glutamic Acid; Heme Oxygenase-1; Humans; Malondialdehyde; Neurodegenerative Diseases; Neuroprotective Agents; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Phosphatidylinositol 3-Kinases; Reactive Oxygen Species; Saponins; Signal Transduction | 2022 |
Esculentoside A exerts anti-inflammatory activity in microglial cells.
Topics: Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Dinoprostone; Humans; Lipopolysaccharides; Microglia; Neurodegenerative Diseases; Neurogenic Inflammation; NF-kappa B; Nitric Oxide; NLR Family, Pyrin Domain-Containing 3 Protein; Oleanolic Acid; Phytolaccaceae; Rats; Saponins; Signal Transduction | 2017 |
Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Antioxidants; Antiparkinson Agents; Autophagy; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Disease Models, Animal; Dopaminergic Neurons; Microtubule-Associated Proteins; Neurodegenerative Diseases; Oleanolic Acid; Oxidative Stress; Parkinson Disease | 2017 |
Inhibition of Nitric Oxide Production in BV2 Microglial Cells by Triterpenes from Tetrapanax papyriferus.
Topics: Anti-Inflammatory Agents; Araliaceae; Cyclooxygenase 2; Cytokines; Gene Expression Regulation; Humans; Inflammation; Lipopolysaccharides; Microglia; Neurodegenerative Diseases; Nitric Oxide; Oleanolic Acid; Plant Extracts; Plant Leaves; Plants, Medicinal | 2016 |
Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke.
Topics: Animals; Antineoplastic Agents; Brain; Chemical Fractionation; Disease Models, Animal; Female; Glucose; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Nerium; Neurodegenerative Diseases; Neuroprotective Agents; Oleanolic Acid; Organ Culture Techniques; Oxygen; Plant Extracts; Rats, Sprague-Dawley; Stroke | 2016 |
Hederagenin and α-hederin promote degradation of proteins in neurodegenerative diseases and improve motor deficits in MPTP-mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenylate Kinase; alpha-Synuclein; Animals; Autophagy; Cell Line, Tumor; Disease Models, Animal; Drugs, Chinese Herbal; Female; Hedera; Huntingtin Protein; Male; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Oleanolic Acid; PC12 Cells; Rats; Saponins; TOR Serine-Threonine Kinases | 2017 |
Association of early experience with neurodegeneration in aged primates.
Topics: Aging; Animals; Disease Models, Animal; Environment; Macaca mulatta; Neocortex; Neurodegenerative Diseases; Oleanolic Acid; Synaptophysin | 2011 |
Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.
Topics: Animals; Antioxidants; Cell Line, Tumor; Humans; Male; Mice; Mice, Inbred C57BL; Models, Biological; Neurodegenerative Diseases; NF-E2-Related Factor 2; Oleanolic Acid; Rats; Rats, Inbred Lew; Terpenes; Transcription, Genetic | 2009 |
Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Line; Cell Nucleus; Disease Models, Animal; Inflammation; Major Histocompatibility Complex; Mice; Mice, Transgenic; Mitochondria; Neurodegenerative Diseases; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Proteins; RNA, Messenger; Signal Transduction; Superoxide Dismutase; Vesicular Transport Proteins | 2011 |